Summary
Chemotherapy of malignant glioma has been discussed in relation to recent advances in experimental and clinical studies. It is now obvious that chemotherapy is of increasing importance in the multidisciplinary treatment of malignant gliomas. Survival time of patients was prolonged by intensive and prolonged chemotherapy and by second treatment upon tumour recurrence. Further progress of chemotherapy will be gained by the progressive accumulation of all experiences, however small, in all the varied routes of approach.
Similar content being viewed by others
References
Blasberg, R. G.: Pharmacodynamics and the bloodbrain barrier. Nat. Cancer Inst. Monogr. 46 (1977) 19–27
Blasberg, R. G.: Pharmacokinetics and metastatic brain tumour chemotherapy. pp 146–164, In: Weiss, L., H. A. Gilbert, J. B. Posner (eds): Brain Metastasis, G. K. Hall and Co., Boston, 1980
Blasberg, R. G., J. Gazendam, C. S. Patlak: Changes in blood-brain transfer parameters induced by hyperosmolar intracarotid infusion and by metastatic tumour growth. pp 307–319, In: Eisenberg, H., R. L. Suddith, (eds): The Cerebral Microvasculature, Plenum Publishing Co., 1980
Brain Tumour Study Group of Japan: Controlled study of the effect of ACNU with radiotherapy for malignant glioma. 41st Congress of the Japan Neurosurgical Society, Tokyo 1982
Chin, H. W., A. B. Young, Y. Maruyama: Survival response of malignant gliomas to radiotherapy with or without BCNU or methyl-CCNU chemotherapy at the University of Kentucky Medical Center. Cancer Treat. Rep. 65, (1981) 41–45
E. O. R. T. C. Brain Tumour Group: Effect of CCNU on survival, rate of objective remission and duration of free interval in patients with malignant brain glioma. Final evaluation. Europ. J. Cancer 14 (1978) 815–856
E. O. R. T. C. Brain Tumour Group. Evaluation of CCNU, VM-26 plus CCNU, and procarbazine in supratentorial brain gliomas. Final evaluation of a randomized study. J. Neurosurg. 55 (1981) 27–31
Fewer, D., C. B. Wilson, E. B. Boldrey: The chemotherapy of brain tumours. Clinical experience with carmustine (BCNU) and vincristine. JAMA 222: 549–552, (1972)
Gutin, P. H., C. B. Wilson, A. R. V. Kumar: Phase II study of procarbazine, CCNU, and vincristine combination chemotherapy in the treatment of malignant brain tumours. Cancer 35 (1975) 1398–1404
Hasegawa, H., J. C. Allen, B. M. Metha: Enhancement of CNS penetration of methotrexate by hyperosmolar intracarotid mannitol and carcinomatous meningitis. Neurology 29 (1979) 1280–1286
Hasegawa, H., Y. Ushio, T. Hayakawa,: Changes of the blood-brain barrier in experimental metastatic brain tumours. J. Neurosurg. 59 (1983) 304–310
Hildebrand, J., J. Brihaye, L. Wagenknecht,: Combination chemotherapy with 1-(2-chloroethyl-3-cyclohexyl-nitrosourea) (CCNU), vincristine and methotrexate in primary and metastatic brain tumours. A preliminary report. Europ. J. Cancer 9 (1973) 627–634
Hochberg, F. H., L. M. Parker, T. Takvorian,: Highdose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme. J. Neurosurg. 54 (1981) 455–460
Hoshino, T., C. B. Wilson, M. L. Rosenblum: Chemotherapeutic implications of growth fraction and cell cycle time in glioblastomas. J. Neurosurg. 43 (1975) 127–135
Hoshino, T., Chemotherapy of malignant brain tumours: Biology and pharmacokinetics. Noshinkeigeka 8 (1980) 1007–1016 (in Japanese)
Kristiansen, K., S. Hagen, T. Kollevold: Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time. A prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 47 (1981) 649–652
Khan, A. B., B. J. D'Souza, M. D. Wharam: Cisplatin therapy in recurrent childhood brain tumours. Cancer Treat. Rep. 66 (1982) 2013–2020
Kumar, A. R. V., J. Renaudin, C. B. Wilson,: Procarbazine hydrochloride in the treatment of brain tumours: Phase 2 study. J. Neurosurg. 40 (1974) 365–371
Lassman, L. P., G. W. Pearce, J. Gang: Sensitivity of intracranial gliomas to vincristine sulphate. Lancet 1 (1965) 296–298
Levin, V. A., P. Kabra: Effectiveness of the nitrosoureas as a function of their lipid solubility in the chemotherapy of experimental rat brain tumours. Cancer Chemother. Rep. 58 (1974) 787–792
Levin, V. A., C. B. Wilson: Chemotherapy: The agents in current use. Sem. Oncology 2 (1975) 63–67
Levin, V. A.., M. Freeman-Dove, H. D. Landahl: Permeability characteristics of brain adjacent of tumours in rats. Arch. Neurol. 32 (1975) 785–791
Levin, V. A., D. C. Crafts, C. B. Wilson: BCNU (NSC-409962) and procarbazine (NSC-77213) treatment for malignant brain tumours. Cancer Treat. Rep. 60 (1976) 243–249
Levin, V. A., H. D. Landahl, M. A. Freeman-Dove: The application of brain capillary permeability coefficient measurements to pathological conditions and the selection of agents which cross the blood-brain barrier. J. Pharmacokin. Biopharm. 4 (1976) 499–519
Levin, V. A., W. F. Hoffman, T. L. Pischer: BCNU-5-fluorouracil combination therapy for recurrent malignant brain tumours. Cancer Treat. Re. 62 (1978) 2071–2076
Levin, V. A., C. B. Wilson, R. Davis: A phase III comparison of BCNU, hydroxyurea, and radiation therapy to BCNU and radiation therapy for treatment of primary malignant gliomas. J. Neurosurg. 51 (1979) 526–532
Levin, V. A., M. S. Edwards, D. C. Wright: Modified procarbazine, CCNU, and vincristine (PCV 3) combination chemotherapy in the treatment of malignant brain tumours. Cancer Treat. Rep. 64 (1980) 237–241
Neuwelt, E. A., J. T. Diehl, L. H. Vu: Monitoring of methotrexate delivery in patients with malignant brain tumours after osmotic blood-brain barrier disruption. Ann. Inter. Med. 94 (1981) 449–454
Pouillart. P., G. Mathe, T. H. Thy: Treatment of malignant gliomas and brain metastases in adults with a combination of adriamycin, VM 26 and CCNU. Results of a phase II trial. Cancer 38 (1976)
Pouillart, T., T. Palangie, M. Poisson: Treatment of adult malignant gliomas. Recent Results Cancer Res 68 (1978) 399–407
Rapoport, S. I., M. Hori, I. Klatzo: Testing of a hypothesis for osmotic opening of the blood-brain barrier. Am. J. Physiol. 223 (1972) 323–331
Reagan, T. J., H. F. Bisel, D. S. Childs: Controlled study of CCNU and radiation therapy in malignant astrocytoma. J. Neurosurg. 44 (1976) 186–190
Rosen, G., F. Ghavimi, A. Nirenberg: High-dose methotrexate with citrovorum factor rescue for the treatment of central nervous system tumours in children. Cancer Treat Rep. 61 (1977) 681–690
Rosenblum, M. L., A. F. Reynolds, K. A. Smith: Chloroethyl-cyclohexyl nitrosourea (CCNU) in the treatment of malignant brain tumours. J. Neurosurg. 39 (1973) 306–314
Rosenblum, M. L., D. V. Dougherty, C. Reese: Agedependent survival of patients with malignant gliomas: Relationship to cell sensitivity. The U. S.-Japanese Conference on Brain Tumour Therapy, Nikko, Japan, 1981
Rosenstock, J. G., A. E. Evans, L. Schut: Response to vincristine of recurrent brain tumours in children. J. Neurosurg. 45 (1976) 135–140
Seiler, R. W., F. Vassella, H. Markwalder: Combination chemotherapy with VM-26 and CCNU in primary malignant brain tumours. Surg. Neurol. 11 (1979) 237–242
Seiler, R. W., A. Zimmermann, H. Markwalder: Adjuvant chemotherapy with VM-26 and CCNU after operation and radiotherapy of high-grade supratentorial astrocytomas. Surg. Neurol. 13 (1980) 65–68
Shapiro, W. R., D. F. Young: CCNU alone and combined with vincristine (VCR) and procarbazine (PCZ) as chemotherapy for malignant glioma. Proc ASCO 17 (1976) 258
Shapiro, W. R., D. F. Young: Treatment of malignant glioma. A controlled study of chemotherapy and irradiation. Arch. Neurol. 33 (1976) 494–500
Shapiro, W. R., J. B. Posner, Y. Ushio: Treatment of meningeal neoplasms. Cancer Treat. Rep. 61 (1977) 733–743
Shimizu, K., Y. Ushio, T. Hayakawa: Combination chemotherapy with 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl) -3-nitrosourea hydrochloride and bleomycin in meningeal carcinomatosis in rats. Cancer Res. 40 (1980) 1341–1343
Sklansky, B. D., R. S. Mann-Kaplan, A. F. Reynolds: 4′-Dimethyl-epipodophyllotosin-β-D-thenylidene-glucoside (PTG) in the treatment of malignant intracranial neoplasmas. Cancer 33 (1974) 460–467
Takakura, K.: Synchronized chemo-radiotherapy for brain tumours. Shinkei Shinpo 26 (1982) 105–112 (In Japanese with English abstract)
Takeuchi, K.: Effect of bleomycin on brain tumours. Gann 19 (1976) 117–132
Taylor, S. G., L. Nelson, D. Baxter, et al.: Treatment of grade III and IV astrocytoma with dimethyl-triazeno-imidazole carboxamide (DTIC, NSC-45388) alone and in combination with CCNU (NSC-79037) or methyl CCNU (Me. CCNU, NSC-95441). Cancer 36 (1975) 1269–1276
Tranum, B. L., A. Haut, S. Rivkin: A phase II study of methyl CCNU in the treatment of solid tumours and lymphomas: a Southwest Oncology Group study. Cancer 35 (1975) 1148–1153
Ushio, Y., T. Hayakawa, K. Yamada: Phase III study of methyl-CCNU and bleomycin combination chemotherapy in the treatment of malignant glioma. 7th International Congress of Neurological Surgery, Munich, W. Germany, 1981
Uphouse, W. J., N. Oishi: Case Report: Acute leukemia after semustine (methyl-CCNU) therapy. Cancer Treat. Re. 66 (1982) 1593–1594
Walker, M. D., T. A. Strike: An evaluation of methyl-CCNU, BCNU and radiotherapy in the treatment of malignant glioma. Proc A. Assoc. Cancer Res. 17 (1976) 163
Walker, M. D., S. B. Green, D. P. Byar: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N. Engl. J. Med. 303 (1980) 1323–1329
Wilson, C. B., P. Gutin, E. B. Boldrey: Single-agent chemotherapy of brain tumours. A five-year review. Arch. Neurol. 33 (1976) 739–744
Yamada, K., A. M. Bremer, C. R. West: Intraarterial BCNU therapy in the treatment of metastatic brain tumour from lung carcinoma. A preliminary report. Cancer 44 (1979) 2000–2007
Yamada, K., Y. Ushio, T. Hayakawa: Quantitative autoradiographic measurements of blood-brain barrier permeability in the rat glioma model. J. Neurosurg. 57 (1982) 394–398
Young, R. C., M. D. Walker, G. P. Canellos: Initial clinical trials with methyl-CCNU 1-(2-chloroethyl) -3-(4-methyl cyclohexyl)-1-nitrosourea (MeCCNU). Cancer 31 (1973) 1164–1169
Young, B., E. H. Oldfield, W. R. Markesbery: Reoperation for glioblastoma. J. Neurosurg. 55 (1981) 917–921
Zander, E., N. de Tribolet, L. Wagenknecht: Combined chemotherapy with VM 26 and BCNU for recurrent malignant gliomas after operation and irradiation. Acta Neurochir. (Wien) 42 (1978) 97–101
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ushio, Y., Hayakawa, T., Hasegawa, H. et al. Chemotherapy of malignant gliomas. Neurosurg. Rev. 7, 3–12 (1984). https://doi.org/10.1007/BF01743285
Issue Date:
DOI: https://doi.org/10.1007/BF01743285